$0.69-0.12 (-15.21%)
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies.
Celularity Inc. in the Healthcare sector is trading at $0.69 with a market capitalization of $20M. The stock is currently near its 52-week low of $0.67, remaining 55.9% below its 200-day moving average. On fundamentals, Piotroski 1/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-she...
Moby summary of NEXGEL, Inc.'s Q4 2025 earnings call
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has appointed Dr Adrian Kilcoyne to its Scientific Advisory Board, bringing more than 20 years of oncology and immunology drug development experience to the company. Kilcoyne is...
Celularity ( NASDAQ:CELU ) Second Quarter 2025 Results Key Financial Results Revenue: US$5.74m (down 53% from 2Q 2024...
NasdaqCM:CELU 1 Year Share Price vs Fair Value Explore Celularity's Fair Values from the Community and select yours Key...